SACT 3

Speaker Talk Title
Dr. Akshay Sharma Dr. Akshay Sharma
St. Jude Children's Research Hospital, USA
Tailored Gene Therapies Targeting Sickle Cell Anaemia
Dr. Wayne A. Marasco Dr. Wayne A. Marasco
Harvard Medical School, USA
Development of effective Pre-clinical animal models to predict outcomes in Human Trials
Dr. Alok Srivastava Dr. Alok Srivastava
Christian Medical College, Vellore, India
Harnessing Gene Therapy for Hemophilia and the Progress in India

Speaker Talk Title
Dr. Khalid Shah Dr. Khalid Shah
Harvard Medical School, USA
Gene Edited and Engineered Tumor cells:A New Immunotherapeutic Approach for Cancer
Dr. Rajiv Khanna Dr. Rajiv Khanna
QIMR Berghofer Medical Research Institute, Australia
Cellular Immunotherapies for Virus-associated Cancers and Post-transplant Infectious Complications
Dr. Avery D. Posey Dr. Avery D. Posey
Perelman School of Medicine, University of Pennsylvania, USA
Next-generation CARS- Targeting Solid Tumours taking into consideration the Tumour Microenvironment

Speaker Talk Title
Dr. Steven Highfill Dr. Steven Highfill
National Cancer Institute, USA
Novel Manufacturing Process: CAR-T cell expansion platforms yield distinct T cell differentiation states
Mr. Srinidhi Deshpande Mr. Srinidhi Deshpande
Cytiva, CCRM, Canada
Buy vs Build Manufacturing - Autologous CAR T Therapy

Speaker Talk Title
Dr. Hasmukh Jain Dr. Hasmukh Jain
Tata Memorial Hospital, Mumbai, India
The Landscape of CD19-directed CAR T Therapies for B-Lymphomas in Adults
Dr. Carlos Fernandez de Larrea Dr. Carlos Fernandez de Larrea
University of Barcelona, Barcelona, Spain
CAR-T Cells in Multiple Myeloma & Spain's Academic Model for CAR-T Development
Dr. Nirali Shah Dr. Nirali Shah
Cancer Institute, USA
CAR T-cells for Myeloid Malignancies: So Near & Yet So Far
Dr. Stephan A. Grupp Dr. Stephan A. Grupp
Children's Hospital of Philadelphia, USA
Building Better CART Therapies - Reflections of emergent challenges over a decade of CAR T cell therapy
Dr. Ajay Vora Dr. Ajay Vora
University of Sheffield, UK
Replacing chemotherapy with immune therapy in children and young persons with ALL
Dr. Kevin Hay Terry Dr. Kevin Hay Terry
Terry Fox Laboratory, Canada
First in Canada CAR-T Cell Therapy-Building Low Cost and Equitable Treatment Capacity

Speaker Talk Title
Dr. Gaurav Chatterjee Dr. Gaurav Chatterjee
ACTREC, Mumbai, India
Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis
Dr. Nishant Jindal Dr. Nishant Jindal
ACTREC, Mumbai, India
Third Party Virus Specific T-Cells Post Allogenic Transplant
Dr. Swaminathan lyer Dr. Swaminathan lyer
MD Anderson Cancer Center, USA
Off the shelf CAR-T approaches for Lymphoma

Speaker Talk Title
Dr. Peter Marks Dr. Peter Marks
National Cancer Institute, USA
Regulatory Advice to Guide the Development of the Next Wave of Cell Therapies

International Speaker Talk Title
Dr. Anand Govindaluri Dr. Anand Govindaluri
Moderator ImmunoACT
Catalyzing Investments in Cell & Gene therapy Industry

International Speaker Talk Title
Ms. Shalini Jatia Ms. Shalini Jatia
Moderator ImmunoACT
Fire Side Panel Discussion with leading Oncologists, Patient Solution Focused Agencies and Patient Advocate groups
Subscribe to our newsletter for updates

SACT 2025 CONFERENCE